Summary
77 / 100 · Bulios Score
What speaks for it
- Out of every 100 SEK of revenue, 17 SEK is left as net profit.
- It holds more cash than debt: 170.7M kr against 51.8M kr.
- It earns 13 SEK a year on every 100 SEK of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue growth is slowing: 5.9% a year over the last 3 years against 10.0% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 25.7 SEK for 1 SEK of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (SEK)
Diluted EPS (SEK)
- Analyst estimate
Revenue grew by 10.0% a year over 5 years. Over the last 3 years it grew by 5.9% a year. Earnings per share grew by 9.0% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 SEK of revenue goes
- Cost of sales 31 SEK
- Research and development 15 SEK
- Sales and administration 32 SEK
- Taxes and other 4.8 SEK
- Net profit 17 SEK
Net profit, industry median (Medical - Devices) 6.9 SEK
Out of every 100 SEK of revenue, 17 SEK is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 2.12%
- Paid out of profit
- 55%
- Raised in a row
- 1 year
You receive $0.30 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.